Canada Pension Plan Investment Board
BNGO icon

Canada Pension Plan Investment Board’s Bionano Genomics BNGO Stock Holding History

Canada Pension Plan Investment Board’s Portfolio BNGO Stock Details BNGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-17
Closed -$14.6K – 1075
2022
Q4 		$14.6K Sell
17
-10
-37% -$12.6K ﹤0.01% 1120
2022
Q3 		$30K Sell
27
-27
-50% -$35.7K ﹤0.01% 1145
2022
Q2 		$45K Hold
54
– – ﹤0.01% 1184
2022
Q1 		$84K Buy
54
+49
+980% +$66.1K ﹤0.01% 1196
2021
Q4 		$9K Buy
+5
New +$13.4K ﹤0.01% 1402

Other funds holding BNGO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 57.61% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Canada Pension Plan Investment Board's BNGO Position: Q1 2023 in Review

Canada Pension Plan Investment Board sold out of Bionano Genomics (BNGO) in Q1 2023, closing a stake of 17 shares — an estimated $14.6K sold.

Canada Pension Plan Investment Board first reported a position in BNGO in Q4 2021 and held it in 5 quarters. The position peaked at $84K in Q1 2022. 126 funds tracked by Wall St. Rank hold BNGO as of Q1 2023.

  • Canada Pension Plan Investment Board reported no remaining Bionano Genomics position as of Q1 2023 after selling out during the quarter.
  • Canada Pension Plan Investment Board sold 17 Bionano Genomics shares in Q1 2023, an estimated $14.6K.
  • Canada Pension Plan Investment Board first reported a position in Bionano Genomics in Q4 2021 and held it in 5 quarters.
  • Canada Pension Plan Investment Board's Bionano Genomics position peaked at $84K in Q1 2022.
  • 126 funds tracked by Wall St. Rank held Bionano Genomics as of Q1 2023.

Based on Canada Pension Plan Investment Board's 13F filing for Q1 2023, filed 15 May 2023.